Ing. Zuzana Brnoliaková PhD.
Info o účastníkovi: http://www.uef.sav.sk/brnoliakova.htm
Účastníkova publikačná činnosť:
Zobraziť
Zuzana KYSELOVA - BRNOLIAKOVA, MSc., PhD.
List of Publications
1. Bezek S., Brnoliakova Z., Sotnikova R., Knezl V., Paulovicova E., Navarova J., Bauer V.: Monotherapy of experimental metabolic syndrome: I. Efficacy and safety. Interdisc Toxicol, 10(3):81-85, 2017.
2. Knezl V., Sotnikova R., Brnoliakova Z., Stankovicova T., Bauer V., Bezek S.: Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects. Interdisc Toxicol, 10(3):86-92, 2017.
3. Kucerova D., Doka G., Kruzliak P., Turcekova K., Kmecova J., Brnoliakova Z., Kyselovic J., Kirchhefer U., Müller F.U., Krenek P., Boknik P., Klimas J.: Unbalanced upregulation of ryanodine receptor 2 plays a particular role in early development of daunorubicin cardiomyopathy. Am J Transl Res, 7(7):1280-94, 2015.
4. Mezesova L., Jendruchova-Javorkova V., Vlkovicova J., Okruhlicova L., Frimmel K., Navarova J., Kyselova-Brnoliakova Z., Vrbjar N.: Supplementation with n-3 polyunsaturated fatty acids to lipopolysaccharide-induced rats improved inflammation and functional properties of renal Na,K-ATPase. Nutr Res, 33(9):772-79, 2013.
5. Broskova Z., Kyselova Z., Knezl V.: Ischemia-reperfusion injury of the isolated diabetic rat heart: Effect of the antioxidant stobadine. Gen Physiol Biophys, Gen Physiol Biophys, 32(2):285-92, 2013.
6. Kyselova Z.: The nutraceutical potential of natural products in diabetic cataract prevention. J Food Nutr Res, 51(4):185-200, 2012.
7. Dubovicky M., Csaszarova E., Brnoliakova Z., Ujhazy E., Navarova J., Mach M.: Effect of prenatal administration of venlafaxine on postnatal development of rat offspring. Interdiscip Toxicol, 5(2):92-97, 2012.
8. Jankyova S., Kmecova J., Cernecka H., Mesarosova L., Musil P., Brnoliakova Z., Kyselovic J., Babal P., Klimas J.: Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy. Pathol Res Pract, 208(8):452-457, 2012.
9. Isailovic D., Plasencia M.D., Gaye M.M., Stokes S.T., Kurulugama R.T., Pungpapong V., Zhang M., Kyselova Z., Goldman R., Mechref Y., Novotny M.V., Clemmer D.E.: Delineating diseases by IMS-MS profiling of serum N-linked glycans. J Proteome Res, 11(2):576-585, 2012.
10. Mezesova L., Jendruchova-Javorkova V., Vlkovicova J., Kyselova Z., Navarova J., Bezek S., Vrbjar N.: Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol. Mol Cell Biochem, 366(1-2): 41-48, 2012.
11. Kyselova Z.: Toxicological aspects of the use of phenolic compounds in disease prevention. Interdisc Toxicol, 4(4):173-183, 2011.
12. Kyselova Z.: Mass spectrometry-based proteomics approaches applied in cataract research. Mass Spectrom Rev, 30(6):1173-1184, 2011.
13. Sotnikova R., Nedelcevova J., Navarova J., Nosalova V., Drabikova K., Szocs K., Krenek P., Kyselova Z., Bezek S., Knezl V., Drimal J., Broskova Z., Kristova V., Okruhlicova L., Bernatova I., Bauer V.: Protection of the vascular endothelium in experimental situations. Interdisc Toxicol, 4(1):20-6, 2011.
14. Weismann P., Stefek M., Kubikova E., Kyselova Z.: The alternative assessment of rat eye lens opacification in cataract. Folia Medica Cassoviensia, 65(2):31-35, 2010.
15. Klimas J., Kmecova J., Jankyova S., Yaghi D., Priesolova E., Kyselova Z., Musil P., Ochodnicky P., Krenek P., Kyselovic J. Pycnogenol((R)) improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats. Phytother Res, 24(7):969-74, 2010.
16. Kyselova Z.: Different experimental approaches in modelling cataractogenesis – an overview of selenite-induced nuclear caract in rats. Interdisc Toxicol, 3(1):3-14, 2010.
17. Skalska S., Kucera P., Goldenberg Z., Stefek M., Kyselova Z., Jariabka P., Gajdosikova A., Klobucnikova K., Traubner P., Stolc S. Neuropathy in streptozotocin-induced diabetic rats: effects of the antioxidant stobadine in comparison with -lipoic acid. Gen Physiol Biophys, 29:50-8, 2010.
18. Tang Z., Varghese R.S., Bekesova S., Loffredo C., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Goldman R., Ressom H.W.: Identification of N-glycan Serum Markers Associated with Hepatocellular Carcinoma from Mass Spectrometry Data. J Proteome Res, 9(1):104-12, 2010.
19. Goldman R., Ressom H.W., Varghese R.S., Goldman L., Bascug G., Loffredo C.A., Abdel-Hamid M., Gouda I., Ezzat S., Kyselova Z., Mechref Y., Novotny M.V. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res, 15(5):1808-13. 2009.
20. Jankyova S., Kucera P., Goldenberg Z., Yaghi D., Navarova J., Kyselova Z., Stolc S., Klimas J., Racanska E., Matyas S. Pycnogenol® efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytother Res, 23(8):1169-74, 2009.
21. Varghese R.S., Goldman L., An Y., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M., Drake S.K., Goldman R., Ressom H.W.: Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry. Conf Proc IEEE Eng Med Biol Soc, 1:3791-4, 2008.
22. Skalska S., Kyselova Z., Gajdosikova A., Karasu C., Stefek M., Stolc S. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Gen Physiol Biophys, 27(2):106-14, 2008.
23. Ressom H.W., Varghese R.S., Goldman L., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Goldman R. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers. Pac Symp Biocomput:216-27. 2008.
24. Ressom H.W., Varghese R.S., Goldman L., An Y., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Drake S.K., Goldman R. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res, 7(2):603-10, 2008.
25. Isailovic D., Kurulagama R., Plasencia M., Stokes S., Kyselova Z., Goldman R., Mechref Y., Novotny M., Clemmer D.: Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J Proteome Res, 7(3):1109-17, 2008.
26. Kyselova Z., Mechref Y., Kang P., Goetz J.A., Dobrolecki L.E., Hickey R.J., Malkas L.H., Novotny M.V.: Breast cancer diagnosis/prognosis through uantitative measurements of serum glycan profiles. Clin Chem, 54(7):1166-75, 2008.
27. Kang P., Mechref Y., Kyselova Z., Goetz J.A., Novotny M.V.: Comparative glycomic mapping through quantitative permethylation and isotope-stable labeling. Anal Chem, 79(16):6064-73, 2007.
28. Kyselova Z., Mechref Y., Al Bataineh M.M., Dobrolecki L.E., Hickey R.J., Vinson J., Sweeney C.J., Novotny M.V.: Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res, 6(5):1822-32, 2007.
29. Vrbjar N., Strelkova S., Javorkova V., Vlkovicova J., Mezesova L., Stefek M., Kyselova Z., Gajdosikova A.: Effect of the pyridoindole antioxidant stobadine on ATP-utilisation by renal Na,K-ATPase in rats with streptozotocin-induced diabetes. Gen. Physiol Biophys, 26:207–213, 2007.
30. Knezl V., Kyselova Z., Zurova J., Navarova J., Tribulova N., Drimal J.: Effect of acetylcholine and ischaemia/reperfusion injury on the heart with STZ-induced experimental diabetes. Neuro-endocrinology Letters, 27(Supplm. 2):101-104, 2006.
31. Djoubissie P.O., Snirc V., Sotnikova R., Zurova J., Kyselova Z., Skalska S., Gajdosik A., Javorkova V., Vlkovicova J., Vrbjar N., Stefek M.: In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats. Gen Physiol Biophys, 25:415-25, 2006.
32. Sotnikova R., Skalska S., Okruhlicova L., Navarova J., Kyselova, Z., Zurova J., Stefek M., Hozova R., Nosalova V.: Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen Physiol Biophys, 25:289-302, 2006.
33. Vlkovicova J., Javorkova V., Stefek M., Kyselova Z., Gajdosikova A., Vrbjar N.: Effect of the pyridoindole antioxidant stobadine on the cardiac Na(+),K(+)-ATPase in rats with streptozotocin-induced diabetes. Gen Physiol Biophys, 25:111-124, 2006.
34. Kyselova Z., Krizanova L., Soltes L., Stefek M.: SDS-PAGE fingerprinting of oxidatively modified eye lens proteins: implications for diabetic cataract. Journal of Chromatography A, 1084:95-100, 2005.
35. Stefek M., Kyselova Z., Rackova L., Krizanova L.: Oxidative modification of rat eye lens proteins by peroxyl radicals in vitro: protection by the chain-breaking antioxidants stobadine and trolox. Biochimica et Biophysica Acta, 1741:183-190, 2005.
36. Kyselova Z., Garcia S. J., Gajdosikova A., Gajdosik A., Stefek M.: Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiological Research, 4(1):49-56, 2005.
37. Kyselova Z., Gajdosik A., Gajdosikova A., Ulicna O., Mihalova D., Karasu C., Stefek M.: Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats – comparison with vitamin E and BHT. Molecular Vision, 11:56-65, 2005.
38. Stefek M., Gajdosikova A., Gajdosik A., Kyselova Z., Djoubissie P.-O., Krizanova L.: Glycooxidative mechanisms in glucose toxicity: biochemical changes of matrix collagen in diabetic rats. Biologia 60/suppl., 17:109-112, 2005.
39. Vrbjar N., Strelkova S., Stefek M., Kyselova Z., Gajdosikova A.: Effect of the pyridoindole antioxidant stobadine on ATP-utilisation by renal Na,K-ATPase in rats with streptozotocin-induced diabetes. Acta Diabetologica, 41:172-178, 2004.
40. Kyselova Z., Stefek M., Bauer V.: Pharmacological prevention of diabetic cataract. Review. Journal of Diabetes and its Complications, 18:129-140, 2004.
41. Kyselova Z., Rackova L., Stefek M.: Pyridoindole antioxidant stobadine protected bovine serum albumin against hydroxyl radical mediated cross-linking in vitro. Archives of Gerontology and Geriatrics, 36:221-229, 2003.
42. Dercova K., Kyselova Z. Barancikova G., Sejakova Z., Malova A.: Biodegradation and bioremediation of pentachlorophenol. Review. Chemical Lettres, 97: 991-1102, 2003.
43. Dercova K., Kyselova Z., Tothova L., Barancikova G.: Biodegradability and toxicity of chlorophenols. Chemical Lettres, 96: S264-S267, 2002.
Zuzana KYSELOVA - BRNOLIAKOVA, MSc., PhD.
List of Publications
1. Bezek S., Brnoliakova Z., Sotnikova R., Knezl V., Paulovicova E., Navarova J., Bauer V.: Monotherapy of experimental metabolic syndrome: I. Efficacy and safety. Interdisc Toxicol, 10(3):81-85, 2017.
2. Knezl V., Sotnikova R., Brnoliakova Z., Stankovicova T., Bauer V., Bezek S.: Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects. Interdisc Toxicol, 10(3):86-92, 2017.
3. Kucerova D., Doka G., Kruzliak P., Turcekova K., Kmecova J., Brnoliakova Z., Kyselovic J., Kirchhefer U., Müller F.U., Krenek P., Boknik P., Klimas J.: Unbalanced upregulation of ryanodine receptor 2 plays a particular role in early development of daunorubicin cardiomyopathy. Am J Transl Res, 7(7):1280-94, 2015.
4. Mezesova L., Jendruchova-Javorkova V., Vlkovicova J., Okruhlicova L., Frimmel K., Navarova J., Kyselova-Brnoliakova Z., Vrbjar N.: Supplementation with n-3 polyunsaturated fatty acids to lipopolysaccharide-induced rats improved inflammation and functional properties of renal Na,K-ATPase. Nutr Res, 33(9):772-79, 2013.
5. Broskova Z., Kyselova Z., Knezl V.: Ischemia-reperfusion injury of the isolated diabetic rat heart: Effect of the antioxidant stobadine. Gen Physiol Biophys, Gen Physiol Biophys, 32(2):285-92, 2013.
6. Kyselova Z.: The nutraceutical potential of natural products in diabetic cataract prevention. J Food Nutr Res, 51(4):185-200, 2012.
7. Dubovicky M., Csaszarova E., Brnoliakova Z., Ujhazy E., Navarova J., Mach M.: Effect of prenatal administration of venlafaxine on postnatal development of rat offspring. Interdiscip Toxicol, 5(2):92-97, 2012.
8. Jankyova S., Kmecova J., Cernecka H., Mesarosova L., Musil P., Brnoliakova Z., Kyselovic J., Babal P., Klimas J.: Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy. Pathol Res Pract, 208(8):452-457, 2012.
9. Isailovic D., Plasencia M.D., Gaye M.M., Stokes S.T., Kurulugama R.T., Pungpapong V., Zhang M., Kyselova Z., Goldman R., Mechref Y., Novotny M.V., Clemmer D.E.: Delineating diseases by IMS-MS profiling of serum N-linked glycans. J Proteome Res, 11(2):576-585, 2012.
10. Mezesova L., Jendruchova-Javorkova V., Vlkovicova J., Kyselova Z., Navarova J., Bezek S., Vrbjar N.: Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol. Mol Cell Biochem, 366(1-2): 41-48, 2012.
11. Kyselova Z.: Toxicological aspects of the use of phenolic compounds in disease prevention. Interdisc Toxicol, 4(4):173-183, 2011.
12. Kyselova Z.: Mass spectrometry-based proteomics approaches applied in cataract research. Mass Spectrom Rev, 30(6):1173-1184, 2011.
13. Sotnikova R., Nedelcevova J., Navarova J., Nosalova V., Drabikova K., Szocs K., Krenek P., Kyselova Z., Bezek S., Knezl V., Drimal J., Broskova Z., Kristova V., Okruhlicova L., Bernatova I., Bauer V.: Protection of the vascular endothelium in experimental situations. Interdisc Toxicol, 4(1):20-6, 2011.
14. Weismann P., Stefek M., Kubikova E., Kyselova Z.: The alternative assessment of rat eye lens opacification in cataract. Folia Medica Cassoviensia, 65(2):31-35, 2010.
15. Klimas J., Kmecova J., Jankyova S., Yaghi D., Priesolova E., Kyselova Z., Musil P., Ochodnicky P., Krenek P., Kyselovic J. Pycnogenol((R)) improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats. Phytother Res, 24(7):969-74, 2010.
16. Kyselova Z.: Different experimental approaches in modelling cataractogenesis – an overview of selenite-induced nuclear caract in rats. Interdisc Toxicol, 3(1):3-14, 2010.
17. Skalska S., Kucera P., Goldenberg Z., Stefek M., Kyselova Z., Jariabka P., Gajdosikova A., Klobucnikova K., Traubner P., Stolc S. Neuropathy in streptozotocin-induced diabetic rats: effects of the antioxidant stobadine in comparison with -lipoic acid. Gen Physiol Biophys, 29:50-8, 2010.
18. Tang Z., Varghese R.S., Bekesova S., Loffredo C., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Goldman R., Ressom H.W.: Identification of N-glycan Serum Markers Associated with Hepatocellular Carcinoma from Mass Spectrometry Data. J Proteome Res, 9(1):104-12, 2010.
19. Goldman R., Ressom H.W., Varghese R.S., Goldman L., Bascug G., Loffredo C.A., Abdel-Hamid M., Gouda I., Ezzat S., Kyselova Z., Mechref Y., Novotny M.V. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res, 15(5):1808-13. 2009.
20. Jankyova S., Kucera P., Goldenberg Z., Yaghi D., Navarova J., Kyselova Z., Stolc S., Klimas J., Racanska E., Matyas S. Pycnogenol® efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytother Res, 23(8):1169-74, 2009.
21. Varghese R.S., Goldman L., An Y., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M., Drake S.K., Goldman R., Ressom H.W.: Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry. Conf Proc IEEE Eng Med Biol Soc, 1:3791-4, 2008.
22. Skalska S., Kyselova Z., Gajdosikova A., Karasu C., Stefek M., Stolc S. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Gen Physiol Biophys, 27(2):106-14, 2008.
23. Ressom H.W., Varghese R.S., Goldman L., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Goldman R. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers. Pac Symp Biocomput:216-27. 2008.
24. Ressom H.W., Varghese R.S., Goldman L., An Y., Loffredo C.A., Abdel-Hamid M., Kyselova Z., Mechref Y., Novotny M.V., Drake S.K., Goldman R. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res, 7(2):603-10, 2008.
25. Isailovic D., Kurulagama R., Plasencia M., Stokes S., Kyselova Z., Goldman R., Mechref Y., Novotny M., Clemmer D.: Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J Proteome Res, 7(3):1109-17, 2008.
26. Kyselova Z., Mechref Y., Kang P., Goetz J.A., Dobrolecki L.E., Hickey R.J., Malkas L.H., Novotny M.V.: Breast cancer diagnosis/prognosis through uantitative measurements of serum glycan profiles. Clin Chem, 54(7):1166-75, 2008.
27. Kang P., Mechref Y., Kyselova Z., Goetz J.A., Novotny M.V.: Comparative glycomic mapping through quantitative permethylation and isotope-stable labeling. Anal Chem, 79(16):6064-73, 2007.
28. Kyselova Z., Mechref Y., Al Bataineh M.M., Dobrolecki L.E., Hickey R.J., Vinson J., Sweeney C.J., Novotny M.V.: Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res, 6(5):1822-32, 2007.
29. Vrbjar N., Strelkova S., Javorkova V., Vlkovicova J., Mezesova L., Stefek M., Kyselova Z., Gajdosikova A.: Effect of the pyridoindole antioxidant stobadine on ATP-utilisation by renal Na,K-ATPase in rats with streptozotocin-induced diabetes. Gen. Physiol Biophys, 26:207–213, 2007.
30. Knezl V., Kyselova Z., Zurova J., Navarova J., Tribulova N., Drimal J.: Effect of acetylcholine and ischaemia/reperfusion injury on the heart with STZ-induced experimental diabetes. Neuro-endocrinology Letters, 27(Supplm. 2):101-104, 2006.
31. Djoubissie P.O., Snirc V., Sotnikova R., Zurova J., Kyselova Z., Skalska S., Gajdosik A., Javorkova V., Vlkovicova J., Vrbjar N., Stefek M.: In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats. Gen Physiol Biophys, 25:415-25, 2006.
32. Sotnikova R., Skalska S., Okruhlicova L., Navarova J., Kyselova, Z., Zurova J., Stefek M., Hozova R., Nosalova V.: Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen Physiol Biophys, 25:289-302, 2006.
33. Vlkovicova J., Javorkova V., Stefek M., Kyselova Z., Gajdosikova A., Vrbjar N.: Effect of the pyridoindole antioxidant stobadine on the cardiac Na(+),K(+)-ATPase in rats with streptozotocin-induced diabetes. Gen Physiol Biophys, 25:111-124, 2006.
34. Kyselova Z., Krizanova L., Soltes L., Stefek M.: SDS-PAGE fingerprinting of oxidatively modified eye lens proteins: implications for diabetic cataract. Journal of Chromatography A, 1084:95-100, 2005.
35. Stefek M., Kyselova Z., Rackova L., Krizanova L.: Oxidative modification of rat eye lens proteins by peroxyl radicals in vitro: protection by the chain-breaking antioxidants stobadine and trolox. Biochimica et Biophysica Acta, 1741:183-190, 2005.
36. Kyselova Z., Garcia S. J., Gajdosikova A., Gajdosik A., Stefek M.: Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiological Research, 4(1):49-56, 2005.
37. Kyselova Z., Gajdosik A., Gajdosikova A., Ulicna O., Mihalova D., Karasu C., Stefek M.: Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats – comparison with vitamin E and BHT. Molecular Vision, 11:56-65, 2005.
38. Stefek M., Gajdosikova A., Gajdosik A., Kyselova Z., Djoubissie P.-O., Krizanova L.: Glycooxidative mechanisms in glucose toxicity: biochemical changes of matrix collagen in diabetic rats. Biologia 60/suppl., 17:109-112, 2005.
39. Vrbjar N., Strelkova S., Stefek M., Kyselova Z., Gajdosikova A.: Effect of the pyridoindole antioxidant stobadine on ATP-utilisation by renal Na,K-ATPase in rats with streptozotocin-induced diabetes. Acta Diabetologica, 41:172-178, 2004.
40. Kyselova Z., Stefek M., Bauer V.: Pharmacological prevention of diabetic cataract. Review. Journal of Diabetes and its Complications, 18:129-140, 2004.
41. Kyselova Z., Rackova L., Stefek M.: Pyridoindole antioxidant stobadine protected bovine serum albumin against hydroxyl radical mediated cross-linking in vitro. Archives of Gerontology and Geriatrics, 36:221-229, 2003.
42. Dercova K., Kyselova Z. Barancikova G., Sejakova Z., Malova A.: Biodegradation and bioremediation of pentachlorophenol. Review. Chemical Lettres, 97: 991-1102, 2003.
43. Dercova K., Kyselova Z., Tothova L., Barancikova G.: Biodegradability and toxicity of chlorophenols. Chemical Lettres, 96: S264-S267, 2002.
Typ účastníka: Moderátor
Kontakt (pracovisko):
Plný názov Inštitúcie/Organizácie: CEM ÚEFT SAV - Centrum experimentálnej medicíny, org. zložka: Ústav experiementálnej farmakológie a toxikológie, Slovenská akadémia vied
Ulica: Dúbravská cesta 9
PSČ: 841 03
Mesto: Bratislava
Štát: SR
| Názov | Ročník | Sekcia | Abstrakt | Prezentácia | Hodnotenie |
|---|---|---|---|---|---|
| Účastník nemá žiadne príspevky, ktoré by ste mohli vidieť. | |||||
Naši partneri
Generálny partner
Partneri
Špeciálne poďakovanie
Mediálni partneri
Usporiadateľ
© OZ Preveda, Javornícka 21, Banská Bystrica 97411, IČO: 30866740, DIČ: 2022228879, ČÚ: 2628727351/1100
Tento projekt sa uskutočnil vďaka finančnej podpore Nadácie SPP.
www.preveda.sk | Website by Brown.sk
Tento projekt sa uskutočnil vďaka finančnej podpore Nadácie SPP.
www.preveda.sk | Website by Brown.sk